Zhongliu Fangzhi Yanjiu (Nov 2022)

Jinfukang Inhibits Lung Cancer Metastasis by Regulating Immune Senescence

  • YAO Wang,
  • QUE Zujun,
  • YAO Jialiang,
  • YU Pan,
  • LUO Bin,
  • TIAN Jianhui

DOI
https://doi.org/10.3971/j.issn.1000-8578.2022.21.1474
Journal volume & issue
Vol. 49, no. 11
pp. 1134 – 1138

Abstract

Read online

Objective To explore the effect of immune senescence on lung cancer metastasis and reveal the mechanism of Fuzheng traditional Chinese medicine Jinfukang in the prevention and treatment of the metastasis. Methods A lung metastasis model of Lewis lung cancer cells was established in C57BL/6 mice with different ages (15 months, 6 months, and 2 months). Mice in the 6-month-old group were given Jinfukang intragastrically for 42 days. Pulmonary metastasis was analyzed by in vivo imaging, anatomical microscopic observation, and HE staining. The proportion of memory T cells and NK cells in peripheral blood was detected by flow cytometry. Results The lung metastatic tumor formation rate of 15-month-old and 6-month-old mice was significantly higher than that of 2-month-old mice (all P 0.05) and the level of NK cells in peripheral blood was significantly higher (P=0.029) than those in the normal saline group. Conclusion Immune senescence can promote the metastasis of lung cancer. The prolongation of the survival time of mice administered with Jinfukang may be related to delaying immune senescence and increasing the number of NK cells.

Keywords